Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Microbial Testing of MDIs

Posted on By

SOP for Microbial Testing of MDIs

MDI Microbial Testing Procedures

1) Purpose

The purpose of this SOP is to establish the procedures for conducting microbial testing of metered-dose inhalers (MDIs) to ensure they meet microbiological quality standards and are safe for use.

2) Scope

This SOP applies to all personnel involved in the microbial testing of MDIs at the manufacturing facility, including microbiologists and quality control staff.

3) Responsibilities

The responsibilities for this SOP include performing microbial tests accurately, documenting results, and ensuring compliance with regulatory standards. Specific roles include:
Microbiologists: Conduct microbial testing as specified.
Quality Control Staff: Review and document the results of microbial tests.

See also  SOP for Conducting Internal Audits in MDI Production

4) Procedure

4.1 Sample Collection
4.1.1 Collect MDI samples from each batch following the sampling plan.
4.1.2 Label and handle samples to prevent contamination.
4.2 Preparation for Testing
4.2.1 Prepare the testing environment by sterilizing equipment and surfaces.
4.2.2 Prepare culture media and control organisms.
4.3 Microbial Limit Testing
4.3.1 Plate the MDI samples on appropriate culture media.
4.3.2 Incubate the plates under specified conditions (e.g., temperature, time).
4.3.3 Count and record the number

of colony-forming units (CFUs).
4.4 Sterility Testing
4.4.1 Inoculate MDI samples into sterile media.
4.4.2 Incubate the samples under specified conditions.
4.4.3 Observe for any signs of microbial growth.
4.5 Documentation
4.5.1 Record all test results in the microbial testing logbook.
4.5.2 Maintain records of media preparation, control tests, and environmental monitoring.
4.6 Data Analysis
4.6.1 Analyze the microbial data to ensure it meets acceptance criteria.
4.6.2 Investigate any out-of-specification (OOS) results and document findings.
4.7 Reporting
4.7.1 Prepare a microbial testing report summarizing the findings.
4.7.2 Submit the report to the quality assurance department for review and approval.

See also  SOP for Water System Maintenance in MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler
CFU: Colony-Forming Unit
OOS: Out of Specification

6) Documents, if any

Microbial testing records, media preparation logs, and environmental monitoring records should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for microbial testing standards.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Tablet Deduster
Next Post: SOP for Pharmacovigilance Risk Assessment Tool Implementation

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version